Literature DB >> 20074208

Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide.

Sylwia Rodziewicz-Motowidło1, Beata Mickiewicz, Katarzyna Greber, Emilia Sikorska, Lukasz Szultka, Elzbieta Kamysz, Wojciech Kamysz.   

Abstract

The natural antimicrobial cationic peptide protegrin-1 displays a broad spectrum of antimicrobial activity and rapidly kills pathogens by interacting with their cell membrane. We investigated the structure-activity relationships of three protegrin-1 analogues: IB-367 (RGGLCYCRGRFCVCVGR-NH(2)), BM-1 (RGLCYCRGRFCVCVG-NH(2)) and BM-2 (RGLCYRPRFVCVG-NH(2)). Our antimicrobial and antifungal activity studies of these peptides showed that BM-1 was much more active than IB-367 against Gram-positive bacteria and fungi, whereas BM-2 was inactive. The BM-1 peptide showed fourfold reduced haemolysis relative to IB-367, an additional advantage of this peptide. In addition, BM-1 was about 15% cheaper than IB-367 to synthesize. The absence of two cysteine residues in the BM-2 sequence could be the main reason for its unstable conformation and antimicrobial inactivity. The solution structures of these peptides were determined in dimethyl sulphoxide using two-dimensional NMR and restrained molecular dynamics calculations. IB-367 and BM-1 formed short, antiparallel, beta-hairpin structures connected by a type II' beta-turn. The shorter, inactive BM-2 analogue exhibited major and minor conformations (predominantly unordered) in the NMR spectra and was much more flexible.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074208     DOI: 10.1111/j.1742-4658.2009.07544.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  11 in total

1.  New Synthetic Peptides Conjugated to Gold Nanoclusters: Antibiotic Activity Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Y A Prada; Fanny Guzmán; Claudia Ortíz; Rafael Cabanzo; Rodrigo Torres; Enrique Mejía-Ospino
Journal:  Protein J       Date:  2019-10       Impact factor: 2.371

2.  Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients.

Authors:  Katarzyna Garbacz; Wojciech Kamysz; Lidia Piechowicz
Journal:  Virulence       Date:  2016-07-22       Impact factor: 5.882

3.  High-resolution NMR structure of the antimicrobial peptide protegrin-2 in the presence of DPC micelles.

Authors:  K S Usachev; S V Efimov; O A Kolosova; A V Filippov; V V Klochkov
Journal:  J Biomol NMR       Date:  2014-11-28       Impact factor: 2.835

4.  In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds.

Authors:  Gianluca Morroni; Oriana Simonetti; Andrea Brenciani; Lucia Brescini; Wojciech Kamysz; Elzbieta Kamysz; Damian Neubauer; Miriam Caffarini; Monia Orciani; Eleonora Giovanetti; Annamaria Offidani; Andrea Giacometti; Oscar Cirioni
Journal:  Med Microbiol Immunol       Date:  2019-06-18       Impact factor: 3.402

5.  Current developments in the therapy of protozoan infections.

Authors:  Mario Zucca; Dianella Savoia
Journal:  Open Med Chem J       Date:  2011-03-09

6.  Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs.

Authors:  Susu M Zughaier; Pavel Svoboda; Jan Pohl
Journal:  Antibiotics (Basel)       Date:  2014-12

Review 7.  Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response.

Authors:  Derry K Mercer; Deborah A O'Neil
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

8.  Fetal bovine serum albumin inhibits antimicrobial peptide activity and binds drug only in complex with α1-antitrypsin.

Authors:  Wen-Hung Tang; Chiu-Feng Wang; You-Di Liao
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 9.  Recent advances in the field of antimicrobial peptides in inflammatory diseases.

Authors:  Patricia Méndez-Samperio
Journal:  Adv Biomed Res       Date:  2013-06-29

10.  Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens.

Authors:  Xinghong Zhao; Yanli Xu; Jakob H Viel; Oscar P Kuipers
Journal:  ACS Synth Biol       Date:  2021-08-04       Impact factor: 5.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.